Preformulation Studies on Imexon

Author： Kuehl P. J.   Hoye W. L.   Myrdal P. B.  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.32, Iss.6, 2006-06, pp. : 687-697

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphism and preformulation studies of lifibrol

By Franceschini G.   Burger A.   Lettenbichler A.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 49, Iss. 1, 2000-01 ,pp. : 65-72

Elsevier

Access to resources Recommend Favorite

The Preformulation Stability Studies of a Proline Prodrug of Methotrexate

By  

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-07 ,pp. : 622-628

Bentham Science Publishers

Access to resources Recommend Favorite

Chemistry and Pharmacology of Imexon and Related Cyanoaziridines

By  

Current Medicinal Chemistry, Vol. 19, Iss. 33, 2012-11 ,pp. : 5745-5753

Bentham Science Publishers

Access to resources Recommend Favorite

The combination of imexon and dacarbazine has shown potential in patients with advanced malignant melanoma

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage

By Chambin O.   Champion D.   Debray C.   Rochat-Gonthier M.H.   Le Meste M.   Pourcelot Y.  

Journal of Controlled Release, Vol. 95, Iss. 1, 2004-02 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite